Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC487

Vibegron eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    12.12.2024
  • Application published:
    15.1.2025
  • Grant published:
    15.10.2025
  • Max expiry date:
    1.4.2034
  • Medicine name:
    Obgemsa
  • Medicine for children:
    No

Timeline

Today
12.12.2024Application
15.1.2025Publication
15.10.2025Registration
1.4.2034Expires

Marketing license

  • IS authorization number:
    EU/1/24/1822
  • Date:
    16.8.2024
  • Foreign authorization number:
    EU/1/24/1822
  • Date:
    27.6.2024

Owner

  • Name:
    Merck Sharp & Dohme LLC
  • Address:
    126 East Lincoln Ave., P.O. Box 2000, Rahway, New Jersey 07065 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, annar

Deadline until: 17.05.2025

Type: Formgallafrestur, fyrsti

Deadline until: 17.03.2025

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.09.2025

Upload documents